Apolipoproteins and ischaemic heart disease: implications for screening

The Lancet

Volumn 343, Issue 8889, 1994, Pages 75-79

  Wald, N ^a   Watt, H ^a   Bailey, A ^b   Johnson, M ^c   Ledue, T B ^c   Haddow, J ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BUPA Medical Research   (United Kingdom)

^c FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; LIPID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SERUM;

EID: 0028156929     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90814-1     Document Type: Article

References (19)

1. Quantitative determination of serum triglycerides by the use of enzymes
2. Measurement of apolipoprotein A-1 in serum with the Technicon RA-1000 system
3. Immunoturbidimetry of apolipoprotein B in human serum
4. Dextran sulfate-Mg2 + precipitation procedure for quantitation of high-density lipoprotein cholesterol
5. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error
6. Maternal serum screening for Down's syndrome in early pregnancy
7. Cholesterol and coronary heart disease: to screen or not to screen
8. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
9. Mortality in relation to smoking: 20 years' observations on male British doctors
10. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
11. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
12. Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Gottingen risk, incidence, and prevalence study (GRIPS)
13. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
14. Influence of low-density- lipoprotein particle size on measurement of apolipoprotein B
15. New assay of apolipoproteins AI and B by rate nephelometry evaluated
16. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men
17. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants